News

Presents cutting-edge research at major conferences worldwide.
Portraitfoto von Stephan Kerkojus

Introducing Our New Business Director: Stephan Kerkojus

We are thrilled to announce that Stephan Kerkojus has joined our team as our new Business Director

Rationale:
The success of allergen immunotherapy for the treatment of allergic rhinoconjunctivitis is most evident during the respective pollen season. Here, we evaluated the combined symptom and medication score (CSMS) from 3 studies in patients with allergic rhinoconjunctivitis treated with mannan-conjugated birch pollen allergoids (T502).

read more

Job offers